Document is current
Any future updates will be listed below
-
Authors
Galosi, Eleonora https://orcid.org/0000-0002-4464-9982
Costanzo, Rocco
Forcina, Francesca
Morino, Stefania
Antonini, Giovanni
Salvetti, Marco
Lauletta, Antonio
Luigetti, Marco
Romano, Angela
Primiano, Guido
Guglielmino, Valeria
Fionda, Laura
Garibaldi, Matteo
Esposito, Nicoletta
Falco, Pietro
di Pietro, Giuseppe
Truini, Andrea
Leonardi, Luca
-
Funding
Funding for this research was provided by:
Ministero della Salute (GR-2021-12372306)
Alnylam Pharmaceuticals
Università degli Studi di Roma La Sapienza
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 25 April 2024
First Online: 3 May 2024
Declarations
:
: GA, LL and SM received speaker honoraria from SOBI and ALNYLAM and travel grants from SOBI, ALNYLAM and Akcea therapeutics. ML speaker honoraria, travel grants and consulting fees from SOBI, ALNYLAM and PFIZER. EG received speaker honoraria from ALNYLAM.
: This study was carried out according to the principles of the 1964 Declaration of Helsinki. Each enrolled subject provided a written informed consent, and all study data were obtained and elaborated in accordance with our institutional ethical committee regulations. The study protocol was approved by Sapienza University Ethical Committee (UNTTR-19–1, protocol number 275 SA_2019 19/12/2019) and Ethical Committee of Fondazione Policlinico Agostino Gemelli IRCSS (Prot. ID 4108).
